- Home
- AMS vs IBIO Comparison
AMS vs IBIO Comparison
Compare AMS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- IBIO
- Stock Information
- Founded
- AMS 1980
- IBIO 2008
- Country
- AMS United States
- IBIO United States
- Employees
- AMS N/A
- IBIO N/A
- Industry
- AMS Medical Specialities
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- IBIO Health Care
- Exchange
- AMS Nasdaq
- IBIO Nasdaq
- Market Cap
- AMS 17.2M
- IBIO 11.9M
- IPO Year
- AMS N/A
- IBIO N/A
- Fundamental
- Price
- AMS $2.41
- IBIO $0.84
- Analyst Decision
- AMS
- IBIO Strong Buy
- Analyst Count
- AMS 0
- IBIO 2
- Target Price
- AMS N/A
- IBIO $5.50
- AVG Volume (30 Days)
- AMS 3.7K
- IBIO 1.9M
- Earning Date
- AMS 11-12-2025
- IBIO 11-11-2025
- Dividend Yield
- AMS N/A
- IBIO N/A
- EPS Growth
- AMS N/A
- IBIO N/A
- EPS
- AMS N/A
- IBIO N/A
- Revenue
- AMS $29,251,000.00
- IBIO $400,000.00
- Revenue This Year
- AMS $5.06
- IBIO N/A
- Revenue Next Year
- AMS N/A
- IBIO N/A
- P/E Ratio
- AMS N/A
- IBIO N/A
- Revenue Growth
- AMS 26.61
- IBIO 77.78
- 52 Week Low
- AMS $2.27
- IBIO $0.56
- 52 Week High
- AMS $3.59
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- AMS 43.71
- IBIO 52.86
- Support Level
- AMS $2.39
- IBIO $0.77
- Resistance Level
- AMS $2.51
- IBIO $0.97
- Average True Range (ATR)
- AMS 0.07
- IBIO 0.06
- MACD
- AMS -0.01
- IBIO -0.00
- Stochastic Oscillator
- AMS 10.00
- IBIO 36.45
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.